A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing

Title
A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
Authors
Keywords
-
Journal
PHARMACOECONOMICS
Volume 28, Issue 1, Pages 61-74
Publisher
Springer Nature
Online
2009-12-17
DOI
10.2165/11318240-000000000-00000

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started